CANNPAL ANIMAL THERAPEUTICS LIMITED - Announcements

Currently unlisted. Proposed listing date: TBA Add to my watchlist

CannPal Animal Therapeutics Limited is an Australia-based pet pharmaceutical company. The... CannPal Animal Therapeutics Limited is an Australia-based pet pharmaceutical company. The Company is focused on research, developing and commercializing therapeutics for the companion animal health industry, using the compounds derived from the cannabis plants. It is focused on cats and dogs. Its lead drug candidate is CPAT-01, which targets osteosarcoma pain in dogs. It is also engaged in investigating and researching the ability to use cannabidiol derived from the hemp plant for developing a nutraceutical range of products for use in companion animals, including dogs, cats, birds, horses and other domestic animals, without a prescription. It is also developing pharmaceutical therapeutics for chronic pain and appetite stimulation. It is developing nutraceutical products for skin conditions, joint health and digestive health.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

CP1	Implementation of Scheme of Arrangement		18/03/21	98.56KB	Share
CP1	Removal from Official List		18/03/21	215.02KB	Share
CP1	Implementation of CannPal Scheme of Arrangement		18/03/21	75.55KB	Share
CP1	Suspension from Official Quotation	PRICE SENSITIVE	11/03/21	230.74KB	Share
CP1	Change of Director's Interest Notice L Mills		11/03/21	47.34KB	Share
CP1	Lodgement of Court Orders with ASIC	PRICE SENSITIVE	11/03/21	199.03KB	Share
CP1	Court Approves Scheme of Arrangement	PRICE SENSITIVE	10/03/21	98.04KB	Share
CP1	Results of Scheme Meeting		08/03/21	160.7KB	Share
CP1	Half Yearly Report and Accounts	PRICE SENSITIVE	19/02/21	699.54KB	Share
CP1	Scheme of Arrangement Booklet		03/02/21	2.51MB	Share
CP1	Registration of Scheme of Arrangement Booklet		03/02/21	116.08KB	Share
CP1	Court Orders Scheme of Arrangement		02/02/21	100.13KB	Share
CP1	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/21	387.73KB	Share
CP1	AC8: AusCann Leadership Post CannPal Acquisition	PRICE SENSITIVE	08/01/21	127.2KB	Share
CP1	Results of Annual General Meeting		20/11/20	169.09KB	Share
CP1	Chairman and CEO Address AGM 2020		20/11/20	1.48MB	Share
CP1	CannPal and AusCann Enter into Scheme of Arrangement	PRICE SENSITIVE	16/11/20	690.38KB	Share
CP1	AC8: AusCann and CannPal Enter into Scheme of Arrangement		16/11/20	804.77KB	Share
CP1	Trading Halt	PRICE SENSITIVE	13/11/20	496.85KB	Share
CP1	Cash Flow Report and Market Update 30 Sep 2020	PRICE SENSITIVE	29/10/20	323.43KB	Share
CP1	Quarterly Cash Flow Report Market Update 30 Sep 2020	PRICE SENSITIVE	29/10/20	136.76KB	Share
CP1	Notice of Annual General Meeting/Proxy Form		19/10/20	1.13MB	Share
CP1	CannPal Animal Health Investment USA Presentation		13/10/20	1.66MB	Share
CP1	CannPal Commences Product Registration in South Africa	PRICE SENSITIVE	12/10/20	163.16KB	Share
CP1	Appendix 4G		01/10/20	112.4KB	Share
CP1	Annual Report to Shareholders		24/09/20	3.85MB	Share
CP1	Final Director's Interest Notice R Johnston		03/09/20	74.79KB	Share
CP1	Board of Directors Change		28/08/20	107.21KB	Share
CP1	Preliminary Final Report	PRICE SENSITIVE	20/08/20	62.54KB	Share
CP1	Quarterly Cash Flow Report Market Update 30 June 2020	PRICE SENSITIVE	30/07/20	487.7KB	Share
CP1	DermaCann Reduces Atopic Dermatisis Symptoms in Dogs	PRICE SENSITIVE	21/07/20	306.43KB	Share
CP1	Quarterly Cash Flow Report & Market Update 31 March 2020	PRICE SENSITIVE	29/04/20	1.46MB	Share
CP1	FDA Establishes INAD for CPAT-01	PRICE SENSITIVE	11/03/20	191.47KB	Share
CP1	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/20	529.37KB	Share
CP1	Quarterly Cash Flow Report & Market Update 31 Dec 2019	PRICE SENSITIVE	28/01/20	330.65KB	Share
CP1	CannPal Enters into Exclusive Licencing Agreement with CSIRO	PRICE SENSITIVE	06/01/20	436.03KB	Share
CP1	Appendix 3B		03/01/20	97.93KB	Share
CP1	Change of Director's Interest Notice L Mills Updated		10/12/19	46.22KB	Share
CP1	Change of Director's Interest Notice L Mills		09/12/19	46.09KB	Share
CP1	Change of Director's Interest Notice L Mills		05/12/19	46.1KB	Share
CP1	CannPal Removed from Restricted Securities List		04/12/19	172.1KB	Share
CP1	CannPal Presents at Research Life Sciences Conference		28/11/19	2.29MB	Share
CP1	Results of Annual General Meeting		26/11/19	189.94KB	Share
CP1	Chairman's Address to Shareholders		26/11/19	419.86KB	Share
CP1	Change of Director's Interest Notice Geoff Starr		21/11/19	45.7KB	Share
CP1	4C Quarterly Cash Flow Report & Market Update Sept 2019	PRICE SENSITIVE	30/10/19	405.95KB	Share
CP1	Appendix 3B		25/10/19	97.14KB	Share
CP1	Notice of Annual General Meeting/Proxy Form		24/10/19	543.61KB	Share
CP1	Appendix 4G		15/10/19	113.13KB	Share
CP1	Release of securities from escrow		14/10/19	176.43KB	Share
CP1	Preliminary Final Report	PRICE SENSITIVE	30/08/19	53.45KB	Share
CP1	Annual Report to Shareholders 30 June 2019	PRICE SENSITIVE	30/08/19	6.32MB	Share
CP1	Quarterly Report 30 June 2019	PRICE SENSITIVE	31/07/19	640.66KB	Share
CP1	CannPal to present at 2019 Asian Cannabis Investment Summit		26/06/19	2.26MB	Share
CP1	Change of Director's Interest Notice L Mills		24/05/19	46.06KB	Share
CP1	Change in substantial holding		17/05/19	87.76KB	Share
CP1	Change of Director's Interest Notice L Mills		10/05/19	46.2KB	Share
CP1	CannPal CPAT-01 Results Presentation and Research Abstract	PRICE SENSITIVE	06/05/19	720.41KB	Share
CP1	Quarterly Report 31 March 2019	PRICE SENSITIVE	24/04/19	380.13KB	Share
CP1	CannPal Research Abstract to be Published		18/04/19	241.64KB	Share
CP1	Change of Director's Interest Notice R M Johnston		08/03/19	46.1KB	Share
CP1	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/19	912.21KB	Share
CP1	CannPal Receives 2 Key Ethics Approvals to Progress R&D	PRICE SENSITIVE	13/02/19	249.63KB	Share
CP1	Change of Director's Interest Notice Geoff Starr		12/02/19	45.6KB	Share
CP1	Quarterly Cash Flow Report & Market Update December 2018	PRICE SENSITIVE	29/01/19	419.54KB	Share
CP1	Change of Director's Interest Notice R Clifford		09/01/19	46.2KB	Share
CP1	CannPal Completes Phase 1B Cannabinoid Study in Dogs	PRICE SENSITIVE	12/12/18	258.16KB	Share
CP1	Change of Director's Interest Notice R Johnston		20/11/18	395.9KB	Share
CP1	Results of 2018 Annual General Meeting		20/11/18	186.91KB	Share
CP1	2018 AGM Chairman's Address		20/11/18	157.11KB	Share
CP1	Notice of Annual General Meeting/Proxy Form		24/10/18	532.98KB	Share
CP1	Appendix 4C - quarterly	PRICE SENSITIVE	22/10/18	354.22KB	Share
CP1	Change of Director's Interest Notice R Johnston		08/10/18	46.19KB	Share
CP1	Updated Annual Report to Shareholders 30 June 2018		27/09/18	11.29MB	Share
CP1	Appendix 4G 30 June 2018		25/09/18	112.82KB	Share
CP1	Corporate Governance Statement		25/09/18	127.02KB	Share
CP1	Annual Report to Shareholders 30 June 2018		25/09/18	10.95MB	Share
CP1	CannPal Granted FDA Sponsor Fee Waiver		24/09/18	87.14KB	Share
CP1	CannPal Commences Phase 1B Pharmacokinetic & Safety Study	PRICE SENSITIVE	03/09/18	90.36KB	Share
CP1	Preliminary Final Report 30 June 2018	PRICE SENSITIVE	31/08/18	54.23KB	Share
CP1	CannPal enters into MOU with The University of Melbourne	PRICE SENSITIVE	08/08/18	84.17KB	Share
CP1	CannPal Receives Ethics Approval for Phase 1B Dog Study	PRICE SENSITIVE	02/08/18	85.51KB	Share
CP1	Change of Director's Interest Notice RM Johnston		27/07/18	46.19KB	Share
CP1	Appendix 4C - Quarterly 30 June 2018	PRICE SENSITIVE	17/07/18	139.33KB	Share
CP1	CannPal Enters into Research Agreement with Eurofins	PRICE SENSITIVE	04/07/18	86.87KB	Share
CP1	CannPal Research Collaboration with CSIRO	PRICE SENSITIVE	28/06/18	195.88KB	Share
CP1	Non-deal Roadshow Presentation		19/06/18	1.55MB	Share
CP1	Market Update on Studies	PRICE SENSITIVE	18/06/18	89.88KB	Share
CP1	CannPal Enters into Manufacturing Agreement with JayChem	PRICE SENSITIVE	29/05/18	88.63KB	Share
CP1	Appendix 4C - Quarterly 31 March 2018	PRICE SENSITIVE	23/04/18	135.32KB	Share
CP1	CannPal Imports Cannabis Oils for Clinical Trial	PRICE SENSITIVE	27/03/18	85.87KB	Share
CP1	Appendix 3B		06/03/18	95.55KB	Share
CP1	CannPal Further Bolsters its Research Team		27/02/18	92.68KB	Share
CP1	Half Yearly Report and Accounts 31 December 2017	PRICE SENSITIVE	20/02/18	1.52MB	Share
CP1	Escrow Share Release 2 March 2018		19/02/18	99.61KB	Share
CP1	Appendix 4C - Quarterly Cash Flow Report	PRICE SENSITIVE	31/01/18	359.07KB	Share
CP1	Corrected Appendix 3B		08/01/18	255.43KB	Share
CP1	CannPal Granted SME Status by the European Medicines Agency	PRICE SENSITIVE	18/12/17	78.7KB	Share
CP1	Investor Presentation		12/12/17	1.84MB	Share
CP1	Change of Director's Interest Notice L Mills		08/12/17	46.02KB	Share

CP1 Implementation of Scheme of Arrangement
18/03/21		98.56KB	Share
CP1 Removal from Official List
18/03/21		215.02KB	Share
CP1 Implementation of CannPal Scheme of Arrangement
18/03/21		75.55KB	Share
CP1 Suspension from Official Quotation
11/03/21	PRICE SENSITIVE	230.74KB	Share
CP1 Change of Director's Interest Notice L Mills
11/03/21		47.34KB	Share
CP1 Lodgement of Court Orders with ASIC
11/03/21	PRICE SENSITIVE	199.03KB	Share
CP1 Court Approves Scheme of Arrangement
10/03/21	PRICE SENSITIVE	98.04KB	Share
CP1 Results of Scheme Meeting
08/03/21		160.7KB	Share
CP1 Half Yearly Report and Accounts
19/02/21	PRICE SENSITIVE	699.54KB	Share
CP1 Scheme of Arrangement Booklet
03/02/21		2.51MB	Share
CP1 Registration of Scheme of Arrangement Booklet
03/02/21		116.08KB	Share
CP1 Court Orders Scheme of Arrangement
02/02/21		100.13KB	Share
CP1 Appendix 4C - quarterly
29/01/21	PRICE SENSITIVE	387.73KB	Share
CP1 AC8: AusCann Leadership Post CannPal Acquisition
08/01/21	PRICE SENSITIVE	127.2KB	Share
CP1 Results of Annual General Meeting
20/11/20		169.09KB	Share
CP1 Chairman and CEO Address AGM 2020
20/11/20		1.48MB	Share
CP1 CannPal and AusCann Enter into Scheme of Arrangement
16/11/20	PRICE SENSITIVE	690.38KB	Share
CP1 AC8: AusCann and CannPal Enter into Scheme of Arrangement
16/11/20		804.77KB	Share
CP1 Trading Halt
13/11/20	PRICE SENSITIVE	496.85KB	Share
CP1 Cash Flow Report and Market Update 30 Sep 2020
29/10/20	PRICE SENSITIVE	323.43KB	Share
CP1 Quarterly Cash Flow Report Market Update 30 Sep 2020
29/10/20	PRICE SENSITIVE	136.76KB	Share
CP1 Notice of Annual General Meeting/Proxy Form
19/10/20		1.13MB	Share
CP1 CannPal Animal Health Investment USA Presentation
13/10/20		1.66MB	Share
CP1 CannPal Commences Product Registration in South Africa
12/10/20	PRICE SENSITIVE	163.16KB	Share
CP1 Appendix 4G
01/10/20		112.4KB	Share
CP1 Annual Report to Shareholders
24/09/20		3.85MB	Share
CP1 Final Director's Interest Notice R Johnston
03/09/20		74.79KB	Share
CP1 Board of Directors Change
28/08/20		107.21KB	Share
CP1 Preliminary Final Report
20/08/20	PRICE SENSITIVE	62.54KB	Share
CP1 Quarterly Cash Flow Report Market Update 30 June 2020
30/07/20	PRICE SENSITIVE	487.7KB	Share
CP1 DermaCann Reduces Atopic Dermatisis Symptoms in Dogs
21/07/20	PRICE SENSITIVE	306.43KB	Share
CP1 Quarterly Cash Flow Report & Market Update 31 March 2020
29/04/20	PRICE SENSITIVE	1.46MB	Share
CP1 FDA Establishes INAD for CPAT-01
11/03/20	PRICE SENSITIVE	191.47KB	Share
CP1 Half Yearly Report and Accounts
26/02/20	PRICE SENSITIVE	529.37KB	Share
CP1 Quarterly Cash Flow Report & Market Update 31 Dec 2019
28/01/20	PRICE SENSITIVE	330.65KB	Share
CP1 CannPal Enters into Exclusive Licencing Agreement with CSIRO
06/01/20	PRICE SENSITIVE	436.03KB	Share
CP1 Appendix 3B
03/01/20		97.93KB	Share
CP1 Change of Director's Interest Notice L Mills Updated
10/12/19		46.22KB	Share
CP1 Change of Director's Interest Notice L Mills
09/12/19		46.09KB	Share
CP1 Change of Director's Interest Notice L Mills
05/12/19		46.1KB	Share
CP1 CannPal Removed from Restricted Securities List
04/12/19		172.1KB	Share
CP1 CannPal Presents at Research Life Sciences Conference
28/11/19		2.29MB	Share
CP1 Results of Annual General Meeting
26/11/19		189.94KB	Share
CP1 Chairman's Address to Shareholders
26/11/19		419.86KB	Share
CP1 Change of Director's Interest Notice Geoff Starr
21/11/19		45.7KB	Share
CP1 4C Quarterly Cash Flow Report & Market Update Sept 2019
30/10/19	PRICE SENSITIVE	405.95KB	Share
CP1 Appendix 3B
25/10/19		97.14KB	Share
CP1 Notice of Annual General Meeting/Proxy Form
24/10/19		543.61KB	Share
CP1 Appendix 4G
15/10/19		113.13KB	Share
CP1 Release of securities from escrow
14/10/19		176.43KB	Share
CP1 Preliminary Final Report
30/08/19	PRICE SENSITIVE	53.45KB	Share
CP1 Annual Report to Shareholders 30 June 2019
30/08/19	PRICE SENSITIVE	6.32MB	Share
CP1 Quarterly Report 30 June 2019
31/07/19	PRICE SENSITIVE	640.66KB	Share
CP1 CannPal to present at 2019 Asian Cannabis Investment Summit
26/06/19		2.26MB	Share
CP1 Change of Director's Interest Notice L Mills
24/05/19		46.06KB	Share
CP1 Change in substantial holding
17/05/19		87.76KB	Share
CP1 Change of Director's Interest Notice L Mills
10/05/19		46.2KB	Share
CP1 CannPal CPAT-01 Results Presentation and Research Abstract
06/05/19	PRICE SENSITIVE	720.41KB	Share
CP1 Quarterly Report 31 March 2019
24/04/19	PRICE SENSITIVE	380.13KB	Share
CP1 CannPal Research Abstract to be Published
18/04/19		241.64KB	Share
CP1 Change of Director's Interest Notice R M Johnston
08/03/19		46.1KB	Share
CP1 Half Yearly Report and Accounts
25/02/19	PRICE SENSITIVE	912.21KB	Share
CP1 CannPal Receives 2 Key Ethics Approvals to Progress R&D
13/02/19	PRICE SENSITIVE	249.63KB	Share
CP1 Change of Director's Interest Notice Geoff Starr
12/02/19		45.6KB	Share
CP1 Quarterly Cash Flow Report & Market Update December 2018
29/01/19	PRICE SENSITIVE	419.54KB	Share
CP1 Change of Director's Interest Notice R Clifford
09/01/19		46.2KB	Share
CP1 CannPal Completes Phase 1B Cannabinoid Study in Dogs
12/12/18	PRICE SENSITIVE	258.16KB	Share
CP1 Change of Director's Interest Notice R Johnston
20/11/18		395.9KB	Share
CP1 Results of 2018 Annual General Meeting
20/11/18		186.91KB	Share
CP1 2018 AGM Chairman's Address
20/11/18		157.11KB	Share
CP1 Notice of Annual General Meeting/Proxy Form
24/10/18		532.98KB	Share
CP1 Appendix 4C - quarterly
22/10/18	PRICE SENSITIVE	354.22KB	Share
CP1 Change of Director's Interest Notice R Johnston
08/10/18		46.19KB	Share
CP1 Updated Annual Report to Shareholders 30 June 2018
27/09/18		11.29MB	Share
CP1 Appendix 4G 30 June 2018
25/09/18		112.82KB	Share
CP1 Corporate Governance Statement
25/09/18		127.02KB	Share
CP1 Annual Report to Shareholders 30 June 2018
25/09/18		10.95MB	Share
CP1 CannPal Granted FDA Sponsor Fee Waiver
24/09/18		87.14KB	Share
CP1 CannPal Commences Phase 1B Pharmacokinetic & Safety Study
03/09/18	PRICE SENSITIVE	90.36KB	Share
CP1 Preliminary Final Report 30 June 2018
31/08/18	PRICE SENSITIVE	54.23KB	Share
CP1 CannPal enters into MOU with The University of Melbourne
08/08/18	PRICE SENSITIVE	84.17KB	Share
CP1 CannPal Receives Ethics Approval for Phase 1B Dog Study
02/08/18	PRICE SENSITIVE	85.51KB	Share
CP1 Change of Director's Interest Notice RM Johnston
27/07/18		46.19KB	Share
CP1 Appendix 4C - Quarterly 30 June 2018
17/07/18	PRICE SENSITIVE	139.33KB	Share
CP1 CannPal Enters into Research Agreement with Eurofins
04/07/18	PRICE SENSITIVE	86.87KB	Share
CP1 CannPal Research Collaboration with CSIRO
28/06/18	PRICE SENSITIVE	195.88KB	Share
CP1 Non-deal Roadshow Presentation
19/06/18		1.55MB	Share
CP1 Market Update on Studies
18/06/18	PRICE SENSITIVE	89.88KB	Share
CP1 CannPal Enters into Manufacturing Agreement with JayChem
29/05/18	PRICE SENSITIVE	88.63KB	Share
CP1 Appendix 4C - Quarterly 31 March 2018
23/04/18	PRICE SENSITIVE	135.32KB	Share
CP1 CannPal Imports Cannabis Oils for Clinical Trial
27/03/18	PRICE SENSITIVE	85.87KB	Share
CP1 Appendix 3B
06/03/18		95.55KB	Share
CP1 CannPal Further Bolsters its Research Team
27/02/18		92.68KB	Share
CP1 Half Yearly Report and Accounts 31 December 2017
20/02/18	PRICE SENSITIVE	1.52MB	Share
CP1 Escrow Share Release 2 March 2018
19/02/18		99.61KB	Share
CP1 Appendix 4C - Quarterly Cash Flow Report
31/01/18	PRICE SENSITIVE	359.07KB	Share
CP1 Corrected Appendix 3B
08/01/18		255.43KB	Share
CP1 CannPal Granted SME Status by the European Medicines Agency
18/12/17	PRICE SENSITIVE	78.7KB	Share
CP1 Investor Presentation
12/12/17		1.84MB	Share
CP1 Change of Director's Interest Notice L Mills
08/12/17		46.02KB	Share

REFRESH

CANNPAL ANIMAL THERAPEUTICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available